Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-22-010459

Chief Commercial Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Wettig Thane Chief Commercial Officer 2022-02-14 Grant or award +45,000 92,682 D
Derivatives
Wettig Thane Chief Commercial Officer 2022-02-14 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…